Clinical Trial Update: A Study of MabThera Added to Bendamustine or Chlorambucil in Patients With Chronic Lymphocytic Leukemia (MaBLe) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating adding rituximab (MabThera) to bendamustine or chlorambucil in chronic lymphocytic leukemia has completed. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Bendamustine (Bendamustine)
• Chlorambucil (chlorambucil)
• MabThera (rituximab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2015-06-25